New Compliance Directions for Medicare Managed Care Plans and the Impact for Providers
06 December 2024
Foley partner Judy Waltz, co-chair of the firm’s Health Care Practice Group, and senior counsel Allie Shalom are speaking in the Health Care Compliance Association (HCCA) San Francisco Regional Health Care Compliance Conference in the panel “New Compliance Directions for Medicare Managed Care Plans and the Impact for Providers” on December 6.
Attendees will walk away from this panel:
- Understanding the Centers for Medicare & Medicaid Services’/Office of Inspector General’s (OIG) clarified expectations;
- Gaining insights from the Department of Justice/OIG investigations and enforcement; and
- Assessing operational impacts for providers including overpayments, fee-for-service guidelines, two-midnight stays, social determinants of health, and prior authorizations.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.